Univ.-Prof. Dr. med. Christoph Huber
FB 04 - Universitätsmedizin, Johannes Gutenberg-Universität Mainz
- 06131/17-72 81
- 06131/17-66 78
Aulitzky, W.E.; Peschel, C.; Schneller, F. et al.
Biotherapy of chronic myelogenous leukemiaAnnals of hematology. organ of Deutsche Gesellschaft für Hämatologie und Onkologie, Gesellschaft für Thrombose- und Hämostaseforschung, Österreichische Gesellschaft für Hämatologie und Onkologie. Bd. 70. H. 3. Berlin: Springer 1995 S. 113 - 120
Schuler, M.; Huber, C.; Peschel, C.
Cytokines in the pathophysiology and treatment of chronic B-cell malignanciesAnnals of hematology. organ of Deutsche Gesellschaft für Hämatologie und Onkologie, Gesellschaft für Thrombose- und Hämostaseforschung, Österreichische Gesellschaft für Hämatologie und Onkologie. Bd. 71. H. 2. Berlin: Springer 1995 S. 57 - 64
Schwab, R.; Peschel, C.; Despés, D. et al.
Deficient cell cycle control in myeloid cells of patients with newly diagnosted chronic myeloid leukemiaCytok. Molec. Therapy. Bd. Cytok. Molec. Therapy. 1995 S. 281-288
Després, D.; Goldschmitt, J.; Aulitzky, W.E. et al.
Differential effect of type I interferons on hematopoietic progenitor cells: Failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitorsExperimental hematology. official publication of the International Society for Experimental Hematology. Bd. 23. H. 14. Kidlington [u.a]: Elsevier 1995 S. 1431 - 1438
Geissler, Klaus; Peschel, Christian; Niederwieser, Dietger et al.
Effect of interleukin-3 pretreatment on granulocyte-macrophage colony-stimulating factor induced mobilization of circulating haemopoietic progenitor cellsBritish journal of haematology. BJH ; the official journal of the British Society of Haematology. Bd. 91. H. 2. Oxford [u.a.]: Blackwell 1995 S. 299 - 305
Eibl, B.; Greiter, E.; Grünewald, K. et al.
Expression of c-fos correlates with IFN-* responsiveness in Philadelphia chromosome positive chronic myelogenous leukemiaJ. Cytok. Molec. Therapy. Bd. J. Cytok. Molec. Therapy. 1995 S. 29-38
Heil, G.; Chadid, L.; Hoelzer, D. et al.
GM-CSF in a Double-Blind Randomized, Placebo Controlled Trial in Therapy of Adult Patients with De Novo Acute Myeloid Leukemia (AML)Leukemia. the journal of normal and malignant hemopoiese ; official journal of the Leukemia Research Fund U.K. Bd. 9. H. 1. Basingstoke: Nature Publ. Group 1995 S. 3 - 9
Göllner, Gerhard; Aman, M.Javad; Steffens, Hans Peter et al.
Interferon-a (IFN-a) inhibits granulocyte-macrophage colony-stimulating factor (GM-CSF) expression at the post-transcriptional level in murine bone marrow stromal cellsBritish journal of haematology. BJH ; the official journal of the British Society of Haematology. Bd. 91. H. 1. Oxford [u.a.]: Blackwell 1995 S. 8 - 14
Aulitzky, W.; Ellerhorst, J.; Logothetis, C. et al.
Intermittent Low-Dose IFN Gamma Treatment for Metastatic Renal Cell Carcinoma: Analysis of Factors Predicting Clinical Response and Long-Term SurvivalOnkologie. international journal for cancer research and treatment. Bd. 18. H. 4. Basel: Karger 1995 S. 339 - 345
Schönborn, H.; Schuler, M.; Kolbe, K. et al.
Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: Results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemiaAnnals of hematology. organ of Deutsche Gesellschaft für Hämatologie und Onkologie, Gesellschaft für Thrombose- und Hämostaseforschung, Österreichische Gesellschaft für Hämatologie und Onkologie. Bd. 71. H. 4. Berlin: Springer 1995 S. 161 - 168